K. Tigen And C. Cevik, "Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?," CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26, pp.2866-2871, 2010
Tigen, K. And Cevik, C. 2010. Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?. CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26 , 2866-2871.
Tigen, K., & Cevik, C., (2010). Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?. CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26, 2866-2871.
Tigen, MUSTAFA, And Cihan Cevik. "Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?," CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26, 2866-2871, 2010
Tigen, MUSTAFA K. And Cevik, Cihan. "Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?." CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26, pp.2866-2871, 2010
Tigen, K. And Cevik, C. (2010) . "Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?." CURRENT PHARMACEUTICAL DESIGN , vol.16, no.26, pp.2866-2871.
@article{article, author={MUSTAFA KÜRŞAT TİGEN And author={Cihan Cevik}, title={Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?}, journal={CURRENT PHARMACEUTICAL DESIGN}, year=2010, pages={2866-2871} }